Nifedipine long-acting (30 mg tab): Supply issue resolved

Last Updated: 24 April 2024

A global supply issue affected the supply of nifedipine long acting 30 mg tablets.

Affected product

There were global supply issues with nifedipine. Viatris, the supplier, was having difficulty sourcing the Italian 14 packs

Nifedipine

Presentation: Tab long-acting 30 mg
Brand: Mylan Italy (24 hr release)
Unapproved medicine supplied under Section 29
Pharmacode: 2618028
Subsidy: $4.78
Measure / Qty: per 14

Schedule listing for nifedipine(external link)

Note: the 10 mg long-acting tablet is limited to existing patients only. There is no issue affecting the 60 mg long-acting tablet.

Alternatives

Viatris source alternative brands to cover supply. All products had to be supplied under section 29.

30 pack

Brand: Nifedipine Viatris
Unapproved medicine supplied under Section 29.
Pharmacode: 2669595
Subsidy: $10.24
Measure / Qty: per 30

100 pack

Brand: Mylan (24 hr release)
Unapproved medicine supplied under Section 29.
Pharmacode: 2602911
Subsidy: $34.10
Measure / Qty: per 100

Resupplied April 2024

Viatris advise that they have been resupplied with the Mylan Italy (24 hr release) and stock has been released to wholesalers. It may take another 1 to 2 weeks for the product to make its way through the supply chain to pharmacies around the motu.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.